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Multifunctional hybrid-design nanomaterials appears to be a 
promising route to meet current therapeutics needs required for 
efficient cancer treatment. Herein, two efficient heat nano-
generators were combined into a multifunctional single 
nanohybrid (a multi-core iron oxide nanoparticle optimized for 
magnetic hyperthermia, and a gold branched shell with tunable 
plasmonic properties in the NIR region, for photothermal therapy) 
which impressively enhanced heat generation, in suspension or in 
vivo in tumours, opening up exciting new therapeutic 
perspectives. 
Nanomedicine has emerged as a rapidly developing field to face 
current diagnostics and therapeutics challenges.
1
 On the one hand, 
nanoparticles can be activated by a physical stimulus only once it 
has reached its target, thus preventing damaging effects on healthy 
bystander tissues, and on the other hand, several functions can be 
incorporated within a single nanostructure, to provide a synergic 
efficiency by merging multiple therapeutic modalities.
2
 
One promising remotely activated nano-therapy is based on the 
ability of some nanoparticles to generate heat under external 
stimulus.
3
 Currently, gold (plasmonic) and iron oxide (magnetic) 
nanoparticles are the prime candidates for the development of such 
thermo-therapy. Optical excitation of plasmonic nanoparticles by an 
infrared laser causes localized heating that can destroy surrounding 
cancer cells (photothermia).
4
 In the case of magnetic nanoparticles, 
application of a high-frequency alternating magnetic field excites 
the fluctuations of the magnetic moment, the resulting magnetic 
energy being released and dissipated as heat (magnetic 
hyperthermia). In both cases, the size and shape of the 
nanoparticles are crucial.
5
 Indeed, gold nanoparticles such as gold 
nanoshells,
6
 nanostars,
7
 and nanorods
8
 are often preferred due to 
their strong absorption cross sections. Furthermore, the possibility 
of engineering their shapes results in surface plasmon resonances in 
the near infra-red (NIR) region, where light absorption by biological 
tissues is minimal (650-900 nm).
9
 For magnetic nanoparticles, fine-
tuning the shape, magnetization and anisotropy is necessary to 
enhance the heat-generating capacity. New generation of magnetic 
cubic,
10
 cooperative multicores,
11
 or core-shell nanostructures
12
 
have recently reached unprecedented heating capacities. 
Nanoscale combination of materials with magnetic and plasmonic 
properties has drawn particular interest these past few years.
13
 
Several novel developments and recent reports in magneto-
plasmonic multifunctional platforms have demonstrated a 
synergistic potential resulting from the association of both 
materials.
14
 For example iron oxide core nanoparticles with a gold 
shell have been synthesized to enable molecular optical and 
magnetic resonance imaging (MRI) in combination with gold 
photothermal therapy of cancer cells.
14a
 Nano-transducers with a 
superparamagnetic iron oxide core embedded in a silica and a gold 
nanoshell have been studied in magnetic targeting and MRI 
detection imaging of brain tumors associated with photothermal 
ablation treatment provided by the gold nanoshell.
14g
 These recent 
developments in magneto-plasmonics have thus mainly focused on 
the use of iron oxide cores for MRI, magnetic manipulation and 
targeting, while gold layers were integrated to provide optical 
response of the hybrids for imaging or photothermal heating. 
Combining efficiently the magnetic hyperthermia potential of iron 
oxide cores and the plasmonic photothermal effects of gold layers 
remains, however, an open challenge. Moreover, beside the 
bimodality in hyperthermia which could be brought by the 
combination of both materials in one single nanostructure, 
magneto-plasmonic nanohybrids allow to guarantee a similar 
biodistribution of iron oxide and gold in tissues,
15
 a rich surface 
chemistry for conjugation due to gold, compared to the iron oxide 
core alone,
16
 and finally a protective shield against the degradation 
of magnetic cores is brought by the gold shell.
17
 Up to date, 
magneto-plasmonic hybrids efficient for both magnetic 
hyperthermia and plasmonic photothermia are rare,
18
 and mapping 
of plasmons at the nanoscale, on an iron oxide core, is still unmet. 
Herein, we propose an efficient class of magneto-plasmonic 
nanoparticles (MagPlasNPs), which combine high thermal 
capabilities for both magnetic hyperthermia and photothermia at 
low excitations doses. We selected two high-performance heat 
nano-generators, a multi-core iron oxide nanoparticle for the 
magnetic part and a gold-branched nanostructure for the plasmonic 
part. Combined elemental and surface plasmon mapping performed 
at the nanoscale on single nanohybrids allowed for an unprecended 
assessment of plasmons on an iron oxide core, and the combination 
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of magnetic and plasmonic properties in the single nanohybrids 
impressively enhanced heat generation, in suspension or in vivo in 
tumours. 
The synthesis of MagPlasNPs was carried out using a seed-mediated 
growth approach as illustrated in Fig. 1a (see experimental section 
in Supplementary Information (SI) for full details).
19
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 (a) The seeding-growth process used for the synthesis of the magneto-plasmonic 
nanoparticles (MagPlasNP) of different ratio Au/Fe: MagPlasNP-1 (Au/Fe = 1.13 ± 0.04), 
MagPlasNP-2 (Au/Fe = 3.1 ± 0.7) and MagPlasNP-3 (Au/Fe = 4.7 ± 0.9). (b-e) STEM-EELS 
analysis of nanohybrids. HAADF image, EELS Fe elemental map (green), EELS O 
elemental map (blue), EELS Au elemental map (red) and overlaid elemental maps are 
shown for (b) MagNP-seeds, (c) MagPlasNP-1, (d) MagPlasNP-2, and (e) MagPlasNP-3. 
(f) Vis-NIR absorption spectra of the different structures. PVP: polyvinylpyrolidone; 
DMF: dimethylformamide. 
 
Maghemite multi-core shape nanoparticles (MagNPs) (average 
diameter 30 ± 4 nm from TEM, see Fig. S1) were synthetized as 
cores for the magneto-plasmonic hybrids and they were prepared 
via the polyol process.
20
 Afterward, their surface was functionalized 
with citrate anions which guaranteed for the seeding step a high 
colloidal stability in ammonia solution (ζ = -80 mV at pH = 10) and 
efficient attraction of [Au(NH3)4]
3+
 that was reduced in the following 
step into Au seeds with NaBH4.
21
 
The resulting magnetic nanoparticles decorated with Au seeds 
(MagNP-seeds) were then redispersed in ethanol in presence of 
polyvinylpyrolidone (PVP) to enable the growth of spiked or 
multibranched gold shells during the step in presence of 
dimethylformamide (DMF), PVP and AuCl4
-
 (see experimental 
section in SI for more details).
22
  Transmission electron microscopy 
images (TEM) are shown in Fig. S1 for MagNP-seeds, with average 
diameter, d ≈ 39 ± 4 nm, MagPlasNP-1, d ≈ 47 ± 6 nm, MagPlasNP-2, 
d ≈ 53 ± 7 nm and MagPlasNP-3, d ≈ 63 ± 11 nm.  
Scanning transmission electron microscopy (STEM) was also 
employed to obtain the chemical images of the different magneto-
plasmonic nanohybrids at the seed stage (MagNP-seeds), and after 
their growth under different synthesis conditions to final 
MagPlasNPs. In each case, high-angle annular dark field (HAADF) 
images are shown together with the chemical maps recorded 
simultaneously using electron energy loss spectroscopy (EELS) in 
Fig. 1 (see also Fig. S2 and S3). As the intensity scattered by an atom 
in HAADF roughly scales as Z
1.7
 where Z is the atomic number,
23
 the 
Au seeds formed after the seeding step appear much brighter than 
the maghemite cores. The Fe, O and Au elemental maps shown 
together in Fig. 1b confirm this chemical contrast and the desired 
complex architecture. Also, the attachment of Au seeds to the 
surface of MagNPs resulted in the appearance of a plasmonic 
shoulder at λ  530 nm originally absent in the spectrum of MagNPs 
(Fig. 1f). This result is expected for discrete gold clusters on iron 
oxide cores,
24
 and is in agreement with the observed brown colour 
of the MagNP-seeds in ethanol. After the growth step, depending 
on the ratio of HAuCl4 to MagNPs available during the growth, we 
observed different organizations and thicknesses of the Au shells. 
For a final ratio of Au/Fe = 1.13 ± 0.04 (MagPlasNP-1, Fig. 1c) the 
size of the seeds increased from ∼ 4 nm to ∼ 10 nm in diameter. 
Moreover, individual quasi-spherical gold nanoparticles 
homogeneously distributed on the surface of maghemite cores with 
an interparticle distance of 10 to 15 nm can be observed. For the 
MagPlasNP-2, characterized by a Au/Fe = 3.1 ± 0.7 ratio, a gold shell 
of thickness reaching 15 to 20 nm around the maghemite cores is 
observed, forming a discontinuous thick shell as highlighted in the 
HAADF image and corresponding chemical maps in Fig. 1d. 
Moreover, the anisotropic shape of the gold particles forming the 
shell is more pronounced and spikes are observed. Finally, for the 
MagPlasNP-3, characterized by a Au/Fe = 4.7 ± 0.9 ratio, the gold 
shell thickness increased to more than 20 nm, so that maghemite 
cores can barely be detected in the core due to the very efficient 
coverage of the gold shell (Fig. 1e). As the concentration of HAuCl4 
in the growth step increased, the interparticle space still present at 
the maghemite surface for MagNP-seeds and MagPlasNP-1 
disappeared completely in MagPlasNP-2 and MagPlasNP-3, in favor 
of a continuous spiky shell formed by merging gold nanoparticles of 
larger sizes. These results are in excellent agreement with 
conventional TEM observations (Fig. S1) and with the results 
obtained by UV-Vis-NIR spectroscopy (Fig. 1f). Indeed the 
suspension became blue and the resonance, red-shifted indicating 
growth and merging of Au seeds into spiky shells. Such shift was 
reported by other groups after growth of Au shells on magnetite 
iron oxide cores.
2a, 25
 Beside the optical properties in the NIR, the 
superparamagnetic behavior of the iron oxide core remains 
unmodified by the gold shell (Fig. S4). Finally, the mean 
hydrodynamic diameters of all NPs were measured by dynamic light 
scattering (DLS, Fig. S5) and by recording their Brownian motions 
(Nanosight, Fig. S6). It increased from MagNPs to MagPlasNP-3, and 
was found higher than the TEM measurements due to the hydration 
of the multi-layered PVA,
26
 but never exceeding 200 nm, revealing 
the absence of any aggregation. The colloidal stability of the 
MagNPs and MagPlasNPs after dispersion in physiological media 
(phosphate buffer solution (PBS), fetal bovine serum (FBS) and 
plasma) was also checked using DLS (Fig. S7). While citrated 
MagNPs quickly destabilized, MagPlasNPs showed a remarkable 
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stability evidencing the role of the PVP coating.The plasmonic 
response of isolated MagPlasNP-2 hybrids was then investigated at 
the nanoscale using STEM-EELS (Fig. 2).
27
  
 
Fig. 2 Surface plasmon resonance of a single nanohybrid MagPlasNP-2. (a) High-angle 
annular dark field (HAADF) image and electron energy loss spectroscopy (EELS) 
elemental maps of a single nanohybrid (MagPlasNP-2), confirming the presence of an 
iron oxide core of ∼ 30 nm in diameter covered with a ∼ 20 nm thick discontinuous Au 
shell. (b) Surface plasmon resonance map (smoothed) corresponding to the 1.4-2.4 eV 
energy range. The contour of the nanohybrid is superimposed to the map. (c) EELS 
corresponding to four different beam positions around the nanohybrid. A single broad 
resonance is observed at ∼ 2.0 eV (λ  620nm) is observed. Raw data are shown. 
The EELS map shown in Fig. 2b, corresponding to the integrated 
intensity in the 1.4-2.4 eV energy range highlights a localized 
surface plasmon resonance around the nanohybrid. The raw 
spectra displayed in Fig. 2c correspond to different positions of the 
electron beam around the nanohybrid as indicated in the sketch in 
the inset. A broad surface plasmon resonance is consistently 
observed at ~ 2.0 +/- 0.2 eV (λ ∼ 620 nm). Slight shifts of the 
surface plasmon resonance, such as the one observed in position C, 
can be assigned to the local variations of the shape of the Au 
nanocrystals forming the shell. The different assemblies of 
nanohybrids observed display a sizeable dispersion in their surface 
plasmon resonance energies, ranging from the visible (λ ∼ 560 nm) 
to the near infrared (λ ∼ 855 nm) regions, as well as in the number 
of distinguishable modes (see also Fig. S8 and S9). These results, 
obtained on single or multi-maghemite core nanostructures, 
establish an unambiguous relation between their nanoscale and 
macroscopic optical properties. Indeed, the typical optical response 
of an isolated MagPlasNP-2 nanostructure consists primarily in a 
surface resonance at about 620 nm, confirming accurately the UV-
Vis-NIR spectroscopy observations shown in Fig. 1f. Furthermore, 
intrinsic size and shape inhomogeneities combined with the 
formation of anisotropic agglomerates of multi-core nanostructures 
lead to slight energy shifts of the surface plasmon, and even to the 
appearance of multiple modes explaining the sizeable energy 
broadening of the resonance observed in the macroscopic 
measurements. 
Magneto-plasmonic nanohybrids were then subjected to magnetic 
and laser stimulations. First, all nanohybrids were dispersed at [Fe] 
=7 mM in water, and exposed to i) magnetic hyperthermia (MHT) at 
magnetic field of 900 kHz and 25 mT, (ii) 680-nm NIR laser at a 
power density of 0.3 W/cm
2
 (PLASM), and (iii) combined magnetic 
field and laser at the exact same conditions (MHT+PLASM) (Figs. 3a 
and 3b). In the first case (MHT only), the same temperature 
elevation of 6°C was observed for all samples, corresponding to a 
heating power (specific absorption rate (SAR) expressed in W/g of 
iron) at 634 ± 76 W/g, in the range of the highest SAR yet reported. 
This excellent magneto-thermal efficiency is brought by the multi-
core assembly which decreases the surface disorder and enhances 
the magnetic susceptibility, thus potentiating thermal losses.
11
 
During laser exposure at 0.3 W/cm², the temperature elevation was 
tuned by the nanohybrid design, increasing from 2°C for MagNPs, to 
6°C for MagPlasNP-1 and 11°C for MagPlasNP-2 and 3. The 
combination of both magnetic and laser exposures (MHT+PLASM) 
led to a remarkable accumulation effect, reaching 14°C elevation 
for MagPlasNP-1, and up to 18-19°C for MagPlasNP-2 and 3 (see 
also the cumulative effect for a 808 nm-laser excitation in Fig. S10, 
and the influence of laser power density, from 0.1 to 0.5 W/cm
2
 in 
Fig. S11). Second, the MagPlasNP-2 heat generation potential was 
investigated as function of the concentration ([Fe] = 3.5, 7, 15, 30 
and 60 mM) (Figs. 3c-d), using a magnetic coil ensuring biosafety for 
future clinical application (110 kHz, 25 mT). The magnetic heating 
was proportional to the concentration, corresponding to a heating 
power of 170 ± 30 W/g (consistent with the decrease in frequency 
to 110 kHz). The 680 nm laser was used at the same low power 
(0.3 W/cm²), evidencing a saturation of the heating capacity with 
concentration. In the magneto-plasmonic mode, the resulting 
thermal efficiency increased with the concentration, and 
therapeutic temperature elevations over 17°C were achieved in 
very short times (100 s, see Fig. S12 for the temperature profiles) 
for concentrations in the [Fe] = 30-60 mM range.  
The combined heating was finally tested in a mouse animal model 
(Fig. 3e) in order to evaluate its workability in vivo. Before injecting 
in animals, we determined that the nanohybrids were 
biocompatible and effective for tumour cell capture (Fig. S13). This 
biocompatibility, confirms the long-standing and safe record of PVP 
coating in biomedical/pharmaceutical applications.
28
 The thermal 
window to achieve tumor ablation corresponds to 45-48°C 
temperature range. For subcutaneous tumor (initial temperatures 
around 28°C), it means a temperature elevation of 17-20°C. For a 
tumor volume of about 150 mm
3
, we thus chose to inject 
intratumorally 50 µl-suspension of MagPlasNP-2, at [Fe] = 150 mM 
(expected final intratumoral concentration in the 50 mM range, 
corresponding to a potential 18-20°C temperature elevation). The 
collateral tumor was non-injected and considered as control. Both 
magnetic induction and laser irradiation alone showed an efficient 
and rapid thermal performance with a 9-10°C temperature 
increase, while no temperature increase was observed in non-
injected tumor. Under the two stimulations, the heating was 
definitely cumulative, with an increase of almost 20°C, reached 
within 2 min. Moreover, the heating performance was still high 
after 3 days (80% of heating maintained), indicating lasting 
effectiveness (Fig. S14). Histological sections were examined for a 
tumor excised after injection, revealing nanohybrids-rich zones 
around the tumor corona that diffusely penetrate to deeper tissues 
(Fig. S15), confirmed as well by TEM observations (Fig. S16) close 
and far to the injection spot. Nevertheless, the tumoral localization 
of the nanohybrids was sufficient to afford global heating in 
macroscopic zones, even 2 days after injection (see Fig. S14). 
Finally, a preliminary follow-up of the tumor growth was performed 
after the combined treatment, revealing a promising therapeutic 
tumor regression during the 5 following days, in comparison with 
the control tumors (Fig. S17). 
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Fig. 3 Heating efficiency of the nanohybrids. (a,b): Tunability of the heat generation 
with the nanohybrids design. All NPs were dispersed at the same concentration [Fe] = 
7 mM. The magnetic coil used delivered a (900 kHz, 25 mT) magnetic field. 680 nm 
laser was used at 0.3 W/cm². (a): Typical infrared images after 5 min heating of 
magneto-plasmonic nanoparticles (MagPlasNP-1 and MagPlasNP-2) under magnetic 
hyperthermia (MHT), laser irradiation (PLASM) and the combination of both modalities 
(MHT + PLASM) (100 µl sample in 500 µl eppendorf (8 mm-diameter) placed within the 
coil). (b): Average temperature elevation recorded for magnetic (MagNPs) and 
magneto-plasmonic nanoparticles (MagPlasNP-1, MagPlasNP-2 and MagPlasNP-3) 
under the three different heating protocols (c,d): Tunability of the heat generation with 
the nanohybrids (MagPlasNP-2) concentration. MHT was now performed in conditions 
of biosafety (magnetic coil at 110 kHz frequency). Same laser settings were used (680 
nm, 0.3 W/cm²). (c): Typical infrared images after 5 min heating for MagPlasNP-2 at 
[Fe] = 15 and 60 mM (100 µl sample in a home-made 8 mm tube containing a 
cylindrical hole of 3x3x5 mm to be filed with the solution). (d): Average temperature 
elevations recorded in all conditions. The magnetic heating (MHT) increases linearly 
with the concentration, while the laser efficiency (PLASM) saturates at high 
concentrations. As a result, the magneto-plasmonic heating (MHT+PLASM) mostly 
follows the magnetic-related variation with concentration. (e): In vivo hyperthermia 
performance. A solution of [Fe] = 150 mM of MagPlasNP-2 is injected into the tumour 
(T+). (Left): typical infrared thermal imaging pictures after 5 min heating under MHT 
alone (110 kHz, 25 mT), PLASM alone (680 nm, 0.3 W/cm2) and bimodal MHT+PLASM 
(same parameters). (Right) Typical temperature elevation profiles of the injected (T+) 
and non-injected tumours (T-, control tumour) as a function of time for the three 
treatments.  
Conclusions 
To summarize, we have demonstrated that an adequate magneto-
plasmonic design can efficiently combine photothermia with 
magnetic hyperthermia into an efficient bimodal thermo-therapy. 
The proposed stable and biocompatible magneto-plasmonic 
nanohybrids were composed of an iron oxide multi-core optimized 
for high efficiency in magnetic hyperthermia, and a gold shell with 
tunable plasmonic properties in the NIR region. We provided 
nanoscale characterization by mapping for the first time the 
plasmon around a magnetic oxide core, connecting unambiguously 
the optical response of single, isolated nanostructures with that of 
large assemblies. We then demonstrated the versatility of the 
system in generating heat through a remarkable cumulative effect 
when both magnetic and plasmonic modalities were applied 
simultaneously and showed that heating efficiency was maintained 
in in vivo conditions. The tumor temperature can then rapidly reach 
48°C, condition for therapeutic tumor ablation, with dose injected 
10 times lower than for classical magnetic hyperthermia 
treatment.
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